Dornier MedTech Growth Triggers Global Rebranding and Facility Upgrade at its Global Headquarters in Munich
February 16, 2016
MUNICH, GERMANY – Feb 16, 2016 – Dornier MedTech is a global medical device company known for its pioneering technologies and revolutionary therapies in urology. Given the company’s global growth and commitment to developing customer-centric technologies in urology, Dornier MedTech has rebranded and has begun a multi-million Euro facility upgrading at its Global Headquarters in Munich to make it easier for its expanding team and changing buyers to better experience its innovative urology products.
“As the company that pioneered Extracorporeal Shockwave Lithotripsy (ESWL), it is necessary for us to keep on innovating and investing in the things that make our company great – our products, people, and facilities. We consider our current rebranding and facility upgrading efforts as part of the ongoing commitment to continue our customer-focused growth and to serve our customers better,” said Abel Ang, CEO of Dornier MedTech.
“Dornier MedTech is one of the 20 most important employers in the region of Starnberg. It continues to be important that we keep manufacturing activities in this region of Starnberg,” said Mr. Christoph Winkelkötter, Economic Development Board of Starnberg.
Among the modern design elements being implemented as part of the multi-million Euro facility upgrade in Munich include a customer center that will feature interactive touch-screen walls to help customers experience Dornier’s technology; training rooms that will display products for pre-purchase viewing and training; as well as high-speed photography and graphic renderings, by local artists, of shockwaves in various artistic media.
For additional information about Dornier’s rebranding and renovation efforts, please contact Valerie Schopmann at +1.770.514.6160 for an interview. Dornier MedTech will also be participating as an exhibitor at the European Association of Urology’s Annual Conference (EAU) and have team members on-hand for interviews upon request.
About Dornier MedTech – Dornier MedTech is a wholly-owned subsidiary of Accuron Medical Technology group (www.accuron.com) is a medical device company focused on providing leading technology and improving life by delivering scientifically superior products and solutions to physicians and patients involved in urological care. As pioneers of the lithotripsy and a variety of surgical lasers, Dornier’s 40 years of innovation and service has made it one of the most trusted MedTech companies in the industry. Dornier MedTech is headquartered in Munich, Germany with offices and distributors all over the world. For more information, visit www.dornier.com.
About the Accuron Medical Technology Group – The Accuron Medical Technology Group is a privately owned by Temasek Holdings, through the business of Dornier MedTech GmbH, Veredus Laboratories and Advanced Materials Technologies Pte Ltd, provide therapeutic, diagnostic, and medical device manufacturing solutions to customers around the globe. Veredus Laboratories Pte Ltd, specializes in the development, manufacture, and marketing of innovative molecular diagnostic solutions in the clinical, specialty, and custom testing markets based on a proprietary Lab-on-Chip platform. Advanced Materials Technologies Pte Ltd serves the contract manufacturing needs of the medical technology sector through providing materials expertise and high precision engineering capabilities.